Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of β-tubulin: Clinical association with slowly progressive demyelinating polyneuropathy

Neurology

Volumn 48, Issue 1, 1997, Pages 243-248

  Connolly, Anne M ^a   Pestronk, A ^a   Mehta, S ^a   Yee, W C ^a   Green, B J ^b   Fellin, C ^c   Olney, R K ^d   Miller, R G ^e   Devor, W N ^f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Johns Mercy Medical Center   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA TUBULIN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; DEMYELINATING DISEASE; DRUG BLOOD LEVEL; ELECTROPHYSIOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; MALE; POLYNEUROPATHY; PRIORITY JOURNAL; REMYELINIZATION; TARGET CELL;

EID: 0031037409     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.243     Document Type: Article

References (44)

1. Dyck P, Lais A, Ohta M, Bastron JA, Okazake H, Groover R. Chronic inflammatory polyradiuculoneuropathy. Mayo Clin Proc 1975;50:621-637.
2. Krendel DA, Parks HP, Anthony DC, St. Clair MB, Graham DG. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1989;12:257-264.
3. Austin JH. Recurrent polyneuropathies and their corticoste-roid treatment. Brain 1958;81:159-192.
4. Dalakas MC, Houff SA, Engel WK, Madden DL, Sever JL. CSF "monoclonal" bands in chronic relapsing polyneuropathy. Neurology 1980;30:864-867.
5. Dyck P, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
6. Sladky JT, Brown MJ; Herman PH. Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid responsive disorder. Ann Neurol 1986;20:76-81.
7. Dyck PJ, O'Brien P, Swanson C, Low P, Daube J. Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology 1985;35:1173-1176.
8. Server AC, Lefkowith J, Braine H, McKhann GM. Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann Neurology 1979;6:258-261.
9. Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986;314:461-456.
10. van Doom PA, Brand A, Strengers PF, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 1990;40:209-212.
11. Brostoff S, Burnett P, Lampert P, Eylar EH. Isolation and characterization of a protein from sciatic nerve myelin responsible for experimental allergic neuritis. Nature New Biol 1972; 235:210-212.
12. Kadlubowski M, Hughes RA. Identification of the neuritogen for experimental allergic neuritis. Nature 1979;277:140-141.
13. Milner P, Lovelidge CA, Taylor WA, Hughes RA. PO myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 1987;79:275-285.
14. Saida T, Saida K, Silberberg DH, Brown JK. Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 1981;9(suppl):87-101.
15. Connolly AM, Pestronk A, Trotter JL, Feldman EL, Cornblath DR, Olney RK. High titer selective serum anti-β-tubulin anti-bodies in chronic inflammatory demyelinating polyneuropathy. Neurology 1993;43:557-562.
16. ALS CNTF Treatment Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996;46:1244-1249.
17. Pearson WR, Lipman DJ. Improved tools for biological se-quence comparison. Proc Natl Acad Sci USA 1988;85:2444-2448.
18. Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
19. Feasby T, Brown WF, Gilbert JJ, Hahn AF. The pathological basis of conduction block in human neuropathies. J Neurol Neurosurg Psychiatry 1985;48:239-244.
20. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964.
21. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 1993;43:2202-2209.
22. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiuloneuropathy, without and with monoclonal gammopathy. Brain 1995;118:359-368.
23. Pestronk A, Li F, Griffin J, et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991;41:357-362.
24. Nobile-Orazio E, Francomano E, Daverio R, et al. Antimyelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. Ann Neurol 1989;26: 543-550.
25. Latov N. Waldenstrom's macroglobulinemia and nonmalignant IgM monoclonal gammopathies. In: Kelly JJ, Kyle RA, Latov N, eds. Polyneuropathies associated with plasma cell dyscrasia. Boston: Martinus Nijhoff, 1987:51-72.
26. Ilyas SS, Quarles RH, McIntosh TD, et al. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci USA 1984;81:1225-1229.
27. Steck AJ, Murray N, Dellagi K, Brouet JC, Seligmann M. Peripheral neuropathy associated with monoclonal IgM auto-antibody. Ann Neurol 1987;22:764-767.
28. Pestronk A, Chaundhry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990;27:316-326.
29. Pestronk S. Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991;14:927-936.
30. Avrameas S, Ternynck T. The natural autoantibodies system: between hypotheses and facts. Mol Immunol 1993;30:1133-1142.
31. Matthes T, Dighiero G. Detection of private and recurrent idiotopes on natural anti-tubulin antibodies by monoclonal anti-idiotopic antibodies. J Immunol 1988;140:148-154.
32. Matthes T, Wolff A, Soubiran P, Gros F, Dighiero G. Antitubulin antibodies. II. Natural autoantibodies and induced antibodies recognized different epitopes on the tubulin molecule. J Immunol 1988;141:3135-3141.
33. Rusanen H, Majamaa K, Tolonen U, Remes AM, Myllyla R, Hassinen IE. Demyelinating polyneuropathy in a patient with the tRNA(LeuXUUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology 1995;45:1188-1192.
34. Rousett B, Viallette B, Bernier-Valentin F, Vague P, Beylot M, Mornex R. Anti-tubulin antibodies in recent onset Type 1 (insulin-dependent) diabetes mellitus: comparison with islet cell antibodies. Diabetologia 1984;27:427-432.
35. Rousset B, Bernier-Valentin F, Poncet C, Orgiazzi AM, Monier JC, Mornex R. Anti-tubulin antibodies in autoimmune thyroid disorders. Clin Exp Immunol 1983;52:325-332.
36. Dighiero G, Lymberi P, Monot C, Abuaf N. Serums with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins. Clin Exp Immunol 1990;82:52-56.
37. Edde B, Vandaele S, Darmon M, Soubiran P. Human serum reacting specifically with a subset of b-tubulin isoforms. Biol Cell 1988;62:157-163.
38. Mead GM, Cowin P, Whitehouse JMA. Antitubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody. Clin Exp Immunol 1980;39:328-336.
39. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679.
40. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
41. Roberts M, Willison H, Vincent A, Newsom DJ. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 1994;343:454-455.
42. Yuki N, Sato S, Itoh T, Miyatake T. HLA-B35 and acute axonal polyneuropathy following Camphylobacter infection. Neurology 1991;41:1561-1563.
43. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 1993;33:502-506.
44. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. Philadelphia: F. A. Davis, 1989.